Have a personal or library account? Click to login
Pharmacological and non-pharmacological approaches to life threatening conditions in epilepsy Cover

Pharmacological and non-pharmacological approaches to life threatening conditions in epilepsy

Open Access
|Mar 2020

References

  1. Amare A., Zenebe G., Hammack J., Davey G.: Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Epilepsia, 2008, 49: 600–607.
  2. Annegers J.F.: United States perspective on definitions and classifications. Epilepsia, 1997, 38 (Suppl. 11): S9–S12.
  3. Asadi-Pooya A.A., Nikseresht A., Yaghoubi E., Nei M.: Physical injuries in patients with epilepsy and their associated risk factors. Seizure, 2012, 21: 165–168.
  4. Bagary M.: Epilepsy, antiepileptic drugs and suicidality. Curr. Opin. Neurol., 2011, 24: 177–182.
  5. Banach M., Poplawska M., Blaszczyk B., Borowicz K.K., Czuczwar S.J.: Pharmacokinetic/pharmacodynamic considerations for epilepsy – depression comorbidities. Expert Opin. Drug Metabol. Toxicol., 2016, 12: 1067–1080.
  6. Beghi E.: Accidents and injuries in patients with epilepsy. Expert Rev. Neurother.. 2009, 9: 291–298.
  7. Beghi E., Leone M., Solari A.: Mortality in patients with a first unprovoked seizure. Epilepsia, 2005, 46 (Suppl. 1): 40–42.
  8. Bell G.S., Gaitatzis A., Bell C.L.: Suicide in people with epilepsy: How great is the risk? Epilepsia, 2009, 50: 1933–1942.
  9. Bell G.S., Sander J.W.: Sudden unexpected death in epilepsy. Risk factors, possible mechanisms and prevention: a reappraisal. Acta Neurol. Taiwan., 2006, 15: 72–83.
  10. Bell G.S., Sander J.W.: Suicide and epilepsy. Curr. Opin. Neurol., 2009, 22: 174–178.
  11. Bergfeldt L.: Differential diagnosis of cardiogenic syncope and seizure disorders. Heart, 2003, 89: 353–358.
  12. Błaszczyk B., Czuczwar S.J.: Epilepsy coexisting with depression. Pharmacol. Rep., 2016, 68: 1084–1092.
  13. Camfield C., Camfield P.: Injuries from seizures are a serious, persistent problem in childhood onset epilepsy: A population-based study. Seizure, 2015, 27: 80–83.
  14. Coeytaux A., Jallon P., Galobardes B., Morabia A.: Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology, 2000, 55: 693–697.
  15. Devinsky O., Spruill T., Thurman D., Friedman D.: Recognizing and preventing epilepsy-related mortality: A call for action. Neurology, 2016, 86: 779–786.
  16. Donner E.J., Waddell B., Osland K., Leach J.P., Duncan S., Nashef L., Picot M.C.: After sudden unexpected death in epilepsy: Lessons learned and the road forward. Epilepsia, 2016, 57 (Suppl. 1): 46–53.
  17. Ferrer P., Ballarín E., Sabaté M., Vidal X., Rottenkolber M., Amelio J. et al.: Antiepileptic drugs and suicide: A systematic review of adverse effects. Neuroepidemiology, 2014, 42: 107–120.
  18. Ficker D.M.: Sudden unexplained death and injury in epilepsy. Epilepsia, 2000, 41 (Suppl. 2): S7–S12.
  19. Forsgren L., Hauser W.A., Olafsson E., Sander J.W., Sillanpää M., Tomson T.: Mortality of epilepsy in developed countries: A review. Epilepsia, 2005, 46 (Suppl. 11): 18–27.
  20. Gayatri N.A., Morrall M.C., Jain V, Kashyape P., Pysden K., Ferrie C.: Parental and physician beliefs regarding the provision and content of written sudden unexpected death in epilepsy (SUDEP) information. Epilepsia, 2010, 51: 777–782.
  21. Glauser T., Shinnar S., Gloss D., Alldredge B., Arya R., Bainbridge J. et al.: Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr., 2016, 16: 48–61.
  22. Goldman A.M., Behr E.R., Semsarian C., Bagnall R.D., Sisodiya S., Cooper P.N.: Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention. Epilepsia, 2016, 57 (Suppl. 1): 17–25.
  23. Grabowska-Grzyb A.: Psychic disturbances in epilepsy. Pol. Przegl. Neurol., 2005, 1: 53–59. In Polish
  24. Granbichler C.A., Nashef L., Selway R., Polkey C.E. et al.: Mortality and SUDEP in epilepsy patients treated with vagus nerve stimulation. Epilepsia, 2015, 56: 291–296.
  25. Greydanus D., Patel D., Pratt H.: Suicide risk in adolescents with chronic illness: implications for primary care and specialty pediatric practice: a review. Dev. Med. Child Neurol., 2010, 52: 1083–1087.
  26. Harden C., Tomson T., Gloss D., Buchhalter J., Cross J.H., Donner E. et al.: Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2017, 88: 1674–1680.
  27. Hesdorffer D.C., Berg A.T., Kanner A.M.: An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr., 2010, 10: 137–145.
  28. Hesdorffer D.C., Kanner A.M.: The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm? Epilepsia, 2009, 50: 978–986.
  29. Hesdorffer D.C., Tomson T.: Sudden unexpected death in epilepsy. Potential role of antiepileptic drugs. CNS Drugs, 2013, 27: 113–119.
  30. Hesdorffer D.C., Tomson T., Benn E., Sander J.W., Nilsson L., Langan Y. et al.: Combined analysis of risk factors for SUDEP. Epilepsia, 2011, 52: 1150–1159.
  31. Hirsch L.: Breathing new life into the fight against sudden death in epilepsy. Epilepsy Curr., 2009, 9: 137–139.
  32. Holst A.G., Winkel B.G., Risgaard B., Nielsen J.B., Rasmussen P.V., Haunsø S. et al.: Epilepsy and risk of death and sudden unexpected death in the young: A nationwide study. Epilepsia. 2013, 54: 1613–1620.
  33. Johnston A., Smith P.: Sudden unexpected death in epilepsy. Expert Rev. Neurother.. 2007, 7: 1751–1761.
  34. Jones S., Pahl C., Trinka E., Nashef L.: A protocol for the in-hospital emergency drug management of convulsive status epilepticus in adults. Pract. Neurol., 2014, 14: 194–197.
  35. Kanner A.M., Balabanov A.J.: Psychiatric evaluation in epilepsy surgery. In: Lueders H.O. (ed.), Textbook of epilepsy surgery. Informa Healthcare, London, 2008, 1254–1262.
  36. Kennedy J.D., Hardin K.A., Parikh P., Li C.S., Seyal M.: Pulmonary edema following generalized tonic clonic seizures is directly associated with seizure duration. Seizure, 2015, 27: 19–24.
  37. Kiani R. Tyrer F., Jesu A., Bhaumik S., Gangavati S., Walker G. et al.: Mortality from sudden unexpected death in epilepsy (SUDEP) in a cohort of adults with intellectual disability. J. Intellect. Disabil. Res., 2014, 58: 508–520.
  38. Kinney M.O., Craig J.J., Kaplan P.W.: Hidden in plain sight: Non-convulsive status epilepticus – Recognition and management. Acta Neurol. Scand., 2017, 136: 280–292.
  39. Klenerman P., Sander J.W.A.S., Shorvon S.D.: Mortality in patients with epilepsy: a study of patients in long term residential care. J. Neurol. Neurosurg. Psychiatry, 1993, 56: 149–152.
  40. Knake S., Rosenow F., Vescovi M., Oertel W.H., Mueller H.H., Wirbatz A. et al.: Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia, 2001, 42: 714–718.
  41. Koch-Stoecker S.: Personality disorders as predictors of severe postsurgical psychiatric complications in epilepsy patients undergoing temporal lobe resections. Epilepsy Behav., 2002, 3: 526–531.
  42. Konopko M., Rola R.: Heart rhythm disorders in patients with epilepsy. Neurologia po Dyplomie, 2017, 12: 18–22. Polish.
  43. Kroner B.L., Wright C., Friedman D., Macher K., Preiss L., Misajon J., Devinsky O.: Characteristics of epilepsy patients and caregivers who either have or have not heard of SUDEP. Epilepsia, 2014, 55: 1486–1494.
  44. Kwon O.Y., Park S.P.: Depression and anxiety in people with epilepsy. J. Clin. Neurol., 2014, 10: 175–188.
  45. Lamberts R.J., Thijs R.D., Laffan A., Langan Y., Sander J.W.: Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia, 2012, 53: 253–257.
  46. Lathoo S.D., Sander J.W.: Cause-specific mortality in epilepsy. Epilepsia, 2005, 46 (Suppl. 11): 36–39.
  47. Laxer K., Trinka E., Hirsch L., Cendes F., Langfitt J., Delanty N. et al.: The consequences of refractory epilepsy and its treatment. Epilepsy Behav., 2014, 37: 59–70.
  48. Lee J., Devinsky O.: The role of autonomic dysfunction in sudden unexplained death in epilepsy patients. Rev. Neurol. Dis., 2005, 2: 61–69.
  49. Leestma J.E., Annegers J.F., Brodie M.J.: Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia, 1997, 38: 47–55.
  50. Lowenstein D.H.: Status epilepticus: an overview of the clinical problem. Epilepsia, 1999, 40 (Suppl. 1): S3–S8; discussion S21–S22.
  51. Maguire M.J., Jackson C.F., Marson A.G., Nolan S.J.: Treatments for the prevention of sudden unexpected death in epilepsy (SUDEP). Cochrane Database Syst. Rev., 2016, 7.
  52. Maguire M.J., Weston J., Singh J., Marson A.G.: Antidepressants for people with epilepsy and depression. Cochrane Database Syst. Rev., 2014, 12: CD010682.
  53. Miller W.R., Young N., Friedman D., Buelow J.M., Devinsky O.: Discussing sudden unexpected death in epilepsy (SUDEP) with patients: Practices of health-care providers. Epilepsy Behav., 2014, 32: 38–41.
  54. Miziak B., Blaszczyk B., Chroscinska-Krawczyk M., Danilkiewicz G., Jagiełło-Wójtowicz E., Czuczwar S.J.: The problem of osteoporosis in epileptic patients taking antiepileptic drugs. Expert Opin. Drug Saf., 2014, 13: 935–946.
  55. Mula M.: Do anti-epileptic drugs increase suicide in epilepsy? 10 years after the FDA alert. Exp. Rev. Neurotherapeutics, 2018, 18: 177–178.
  56. Mula M., Kanner A.M., Schmitz B., Schachter S.: Antiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. Epilepsia, 2013, 54: 199–203.
  57. Mula M., Sander J.W.: Suicide risk in people with epilepsy taking antiepileptic drugs. Bipolar Disord., 2013, 15: 622–627.
  58. Nashef L., Richardson M.P.: Introduction – Epilepsy research UK expert workshop 2014. SUDEP: Time for prevention – evidence and clinical translation. Proceedings from the Epilepsy Research UK 2014 Expert Workshop. Epilepsia, 2016, 57 (Suppl. 1): 1–3.
  59. Nashef L., So E.L., Ryvlin P., Tomson T.: Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia, 2012, 53: 227–233.
  60. Nei M., Bagla R.: Seizure-related injury and death. Curr. Neurol. Neurosci. Rep., 2007, 7: 335–341.
  61. Nousiainen U., Mervaala E., Uusitupa M., Ylinen A., Sivenius J.: Cardiac arrhythmias in the differential diagnosis of epilepsy. J. Neurol., 1989, 236: 93–96.
  62. Piskorska B., Miziak B., Czuczwar S.J., Borowicz K.: Safety issues around the safety of antiepileptics. Expert Opin. Drug Saf., 2013, 12: 647–657.
  63. Richerson G.B, Boison D., Faingold C.L., Ryvlin P.: From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in Epilepsy. Epilepsia, 2016, 57 (Suppl. 1): 35–45.
  64. Rugg-Gunn F., Duncan J., Hjalgrim H., Seyal M., Bateman L.: From unwitnessed fatality to witnessed rescue: Nonpharmacologic interventions in sudden unexpected death in epilepsy. Epilepsia, 2016, 57 (Suppl. 1): 26–34.
  65. Ryvlin P., Cucherat M., Rheims S.: Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol., 2011, 10: 961–968.
  66. Ryvlin P., Nashef L., Tomson T.: Prevention of sudden unexpected death in epilepsy: a realistic goal? Epilepsia, 2013, 54 (Suppl. 2): 23–28.
  67. Sajjan S., Jain P., Sharma S., Seth A., Aneja S.: Injuries in children with epilepsy: A hospital based study. Indian Pediatr., 2016, 53: 883–885.
  68. Shankar R., Donner E.J., McLean B., Nashef L., Tomson T.: Sudden unexpected death in epilepsy (SUDEP): what every neurologist should know. Epileptic Disord., 2017, 19: 1–9.
  69. So EL.: Demystifying sudden unexplained death in epilepsy – are we close? Epilepsia, 2006, 47 (Suppl. 1): 87–92.
  70. Spitz M.C.: Injuries and death as a consequence of seizures in people with epilepsy. Epilepsia, 1998, 39: 904–907.
  71. Stöllberger C., Finsterer J.: Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res., 2004, 59: 51–60.
  72. Strzelczyk A., Zschebek G., Bauer S., Baumgartner C., Grond M., Hermsen A. et al.: Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians. Epilepsia, 2016, 57: 612–620.
  73. Tellez-Zenteno J.F., Nguyen R., Hernádez-Ronquillo L.: Injuries, accidents and mortality in epilepsy: a review of its prevalence risk factors and prevention. Rev. Invest. Clin., 2010, 62: 466–479.
  74. Thom M., Michalak Z., Wright G., Dawson T., Hilton D., Joshi A. et al.: Audit of practice in sudden unexpected death in epilepsy (SUDEP) post mortems and neuropathological findings. Neuropathol. Appl. Neurobiol., 2016, 42: 463–476.
  75. Tian N., Cui W., Zack M., Kobau R., Fowler K.A., Hesdorffer D.C.: Suicide among people with epilepsy: A population-based analysis of data from the U.S. National Violent Death Reporting System, 17 states, 2003–2011. Epilepsy Behav., 2016, 61: 210–217.
  76. Tomson T.: Mortality in epilepsy. J. Neurol., 2000, 247: 15–21.
  77. Tomson T., Beghi E., Sundqvist A., Johannessen S.I.: Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res., 2004, 60: 1–16.
  78. Tomson T., Hirsch L.J., Friedman D., Bester N., Hammer A., Irizarry M. et al.: Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials. Epilepsia, 2013, 54: 135–140.
  79. Tomson T., Surges R., Delamont R., Haywood S., Hesdorffer D.C.: Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs. Epilepsia, 2016, 57 (Suppl. 1): 4–16.
  80. Tomson T., Walczak T., Sillanpaa M., Sander J.W.: Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia, 2005, 46 (Suppl. 11): 54–61.
  81. Towne A.R., Pellock J.M., Ko D., DeLorenzo M.J.: Determinants of mortality in status epilepticus. Epilepsia, 1994, 35: 27–34.
  82. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J. et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. Med., 1998, 339: 792–798.
  83. Trinka E., Cock H., Hesdorffer D., Rossetti A.O., Scheffer I.E., Shinnar S. et al.: A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015, 56: 1515–1523.
  84. Vignatelli L., Rinaldi R., Galeotti M., de Carolis P., D’Alessandro R.: Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study. Eur. J. Neurol., 2005, 12: 897–902.
  85. Vignatelli L., Tonon C., D’Alessandro R., Bologna Group for the Study of Status Epilepticus: Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia, 2003, 44: 964–968.
  86. Walczak T.: Do antiepileptic drugs play a role in sudden unexpected death in epilepsy? Drug Saf., 2003, 26: 673–683.
  87. Wirrell E.C.: Epilepsy-related injuries. Epilepsia, 2006, 47 (Suppl. 1): 79–86.
DOI: https://doi.org/10.21307/joepi-2020-002 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Language: English
Page range: 43 - 54
Submitted on: Dec 23, 2019
Accepted on: Mar 12, 2020
Published on: Mar 23, 2020
Published by: The Foundation of Epileptology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2020 Barbara Błaszczyk, Aleksandra Walczak, Natalia Ścirka, Agnieszka Konarzewska, Barbara Miziak, Stanisław J. Czuczwar, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.